Aspirin: Clinical Trials

6 trials for Aspirin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 2 unknown, 1 withdrawn. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Recruiting 3, Unknown 2, Withdrawn 1
Phase 21Unknown 1

Follow Aspirin: new trials by email Literature Review of Aspirin trials Research Report on Aspirin

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Aspirin, Low-molecular-weight heparin - Venous Thromboembolism, Postpartum Period
Phase 3RecruitingUniversity of Calgary88052026-06-042026-07-27
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
Aspirin 150 mg, Placebo - Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia
Phase 3RecruitingCentre Hospitalier Intercommunal Creteil5002021-02-152026-06-12
Aspirin Use for Gastric Cancer Prevention in the Early Gastric Cancer Patients
Aspirin 100mg, Placebo oral tablet - Aspirin, Gastric Cancer
Phase 3RecruitingNational Cancer Center, Korea17002020-02-152024-12-27
Protective Effect of Aspirin on COVID-19 Patients
Aspirin 100mg - Novel Coronavirus Pneumonia, Aspirin
Phase 2 / Phase 3UnknownXijing Hospital1282020-02-102020-04-28
The Effect Of Aspirin On Survival in Lung Cancer
Aspirin 75 mg, no aspirin - Non Small Cell Lung Cancer, Survival
Phase 3WithdrawnLiverpool Heart and Chest Hospital NHS Foundation Trust2010-08-012016-03-07
The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass
aspirin - Coronary Artery Disease, Off-pump Coronary Artery Bypass
Phase 3UnknownChinese Academy of Medical Sciences, Fuwai Hospital2002010-03-012010-12-31

Narrower conditions

Pre-Eclampsia (2)  ·  Abruptio Placentae (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Coronary Artery Disease (1)  ·  Fetal Growth Retardation (1)  ·  Perinatal Death (1)  ·  Postpartum Hemorrhage (1)  ·  Pulmonary Embolism (1)  ·  Stomach Neoplasms (1)  ·  Thrombophilia (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Hypertension, Pregnancy-Induced (2)  ·  Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Obstetric Labor Complications (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Pregnancy Complications (2)  ·  Respiratory Tract Diseases (2)  ·  Urogenital Diseases (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)

Interventions

Aspirin (6)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  N-acetyl-S-(alpha-methyl-4-(2-methylpropyl)benzeneacetyl)cysteine 4-(nitrooxy)butyl ester (1)  ·  Nadroparin (1)  ·  Oxygen (1)  ·  Tinzaparin (1)

Sponsors

Centre Hospitalier Intercommunal Creteil (1)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (1)  ·  Liverpool Heart and Chest Hospital NHS Foundation Trust (1)  ·  National Cancer Center, Korea (1)  ·  University of Calgary (1)  ·  Xijing Hospital (1)

Countries

China (2)  ·  France (2)  ·  Belgium (1)  ·  Canada (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Poland (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Cai Yue (1)  ·  Il Ju Choi, M.D., Ph.D. (1)  ·  Leslie Skeith, MD (1)  ·  Marc Rodger, MD (1)  ·  Mike Mr Poullis, FRCS(CTh) (1)

Results publications

PMID 31772605, PMID 37489818

NIH funding

2018 (1)